Norwegen -
Norwegisch -
Statens legemiddelverk
sandimmun neoral 100 mg
novartis norge (2) - ciklosporin - kapsel, myk - 100 mg
Norwegen -
Norwegisch -
Statens legemiddelverk
trimonil retard 300 mg
desitin arzneimittel gmbh - karbamazepin - depottablett - 300 mg
Norwegen -
Norwegisch -
Statens legemiddelverk
trimonil retard 150 mg
desitin arzneimittel gmbh - karbamazepin - depottablett - 150 mg
Norwegen -
Norwegisch -
Statens legemiddelverk
trimonil retard 600 mg
desitin arzneimittel gmbh - karbamazepin - depottablett - 600 mg
Norwegen -
Norwegisch -
Statens legemiddelverk
venofundin 60 mg/ ml
b. braun melsungen ag - poly(o-2-hydroksyetyl)stivelse - infusjonsvæske, oppløsning - 60 mg/ ml
Norwegen -
Norwegisch -
Statens legemiddelverk
diprotit 0.05 % w/w
evolan pharma ab - betametasondipropionat - Øredråper, oppløsning - 0.05 % w/w
Norwegen -
Norwegisch -
Statens legemiddelverk
diazedor vet. 5 mg/ ml
vetviva richter gmbh - diazepam - injeksjonsvæske, oppløsning - 5 mg/ ml
Norwegen -
Norwegisch -
Statens legemiddelverk
adrenalin ethypharm 1 mg/ ml
ethypharm (1) - adrenalintartrat - injeksjonsvæske, oppløsning - 1 mg/ ml
Europäische Union -
Norwegisch -
EMA (European Medicines Agency)
hemangiol
pierre fabre medicament - propranolol hydroklorid - hemangiom - betablokkende midler - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
Norwegen -
Norwegisch -
Statens legemiddelverk
adrenalin aguettant 0.1 mg/ ml
laboratoire aguettant - adrenalintartrat - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 0.1 mg/ ml